- Home
- NUVB vs ASO Comparison
NUVB vs ASO Comparison
Compare NUVB & ASO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | NUVB | ASO |
|---|---|---|
| Founded | 2018 | 1938 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Recreational Games/Products/Toys |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.9B | 3.3B |
| IPO Year | N/A | 2020 |
Fundamental Metrics
Financial Performance| Metric | NUVB | ASO |
|---|---|---|
| Price | $8.98 | $49.73 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 8 | 17 |
| Target Price | $10.63 | ★ $59.06 |
| AVG Volume (30 Days) | ★ 6.1M | 1.9M |
| Earning Date | 11-03-2025 | 12-09-2025 |
| Dividend Yield | N/A | ★ 1.05% |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ 5.48 |
| Revenue | $26,748,000.00 | ★ $6,011,862,000.00 |
| Revenue This Year | $609.55 | $4.00 |
| Revenue Next Year | $197.91 | $6.22 |
| P/E Ratio | ★ N/A | $9.05 |
| Revenue Growth | ★ 1137.19 | N/A |
| 52 Week Low | $1.54 | $33.34 |
| 52 Week High | $9.75 | $59.25 |
Technical Indicators
Market Signals| Indicator | NUVB | ASO |
|---|---|---|
| Relative Strength Index (RSI) | 61.71 | 45.90 |
| Support Level | $8.84 | $49.90 |
| Resistance Level | $9.75 | $51.64 |
| Average True Range (ATR) | 0.43 | 1.59 |
| MACD | -0.11 | -0.64 |
| Stochastic Oscillator | 56.50 | 3.79 |
Price Performance
Historical ComparisonAbout NUVB Nuvation Bio Inc.
Nuvation Bio Inc is a biopharmaceutical company tackling unmet needs in oncology by developing differentiated and novel therapeutic candidates. Its product candidate, taletrectinib, is an oral, potent, central nervous system-active, selective, next-generation c-ros oncogene 1 (ROS1) inhibitor specifically designed for the treatment of patients with ROS1+ non-small cell lung cancer (NSCLC). In addition, its clinical-stage pipeline includes differentiated, novel oncology product candidates such as Safusidenib, NUV-1511, and NUV-868 in their different stages of development. The company generates revenue through out-licensing collaborative agreements with its customers located in China and Japan.
About ASO Academy Sports and Outdoors Inc.
Academy Sports and Outdoors Inc is engaged in the full-line sporting goods and outdoor recreation retailer in the United States. The company's product categories are outdoors, apparel, sports & recreation, and footwear.